Cloned (Comment) | Organism |
---|---|
amino acid residue 192-1085 expressed in Escherichia coli | Plasmodium falciparum |
His-tagged protein (amino acid residue 79-605) expressed in Escherichia coli | Plasmodium falciparum |
Crystallization (Comment) | Organism |
---|---|
- |
Plasmodium falciparum |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(2S,17S,20S,21R)-21-amino-5-(4-benzoylbenzyl)-2-[4-(hex-5-ynoylamino)butyl]-20-hydroxy-17-(naphthalen-2-ylmethyl)-4,7,16,19-tetraoxo-22-phenyl-9,12-dioxa-3,6,15,18-tetraazadocosan-1-amide | - |
Plasmodium falciparum | |
N-[(2-[2-[(N-[(2S,3R)-3-amino-4-[4-(benzyloxy)phenyl]-2-hydroxybutanoyl]-L-alanyl)amino]ethoxy]ethoxy)acetyl]-4-benzoylphenylalanyl-N6-hex-5-ynoyl-L-lysinamide | - |
Plasmodium falciparum |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
343000 | - |
gel filtration | Plasmodium falciparum |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Plasmodium falciparum | - |
- |
- |
Plasmodium falciparum | Q8IL11 | - |
- |
Purification (Comment) | Organism |
---|---|
- |
Plasmodium falciparum |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-leucyl-7-amido-4-methylcoumarin + H2O | - |
Plasmodium falciparum | L-leucine + 7-amino-4-methylcoumarin | - |
? |
Subunits | Comment | Organism |
---|---|---|
homohexamer | 343000, gel filtration (357000 calculated) | Plasmodium falciparum |
Synonyms | Comment | Organism |
---|---|---|
aminopeptidase N | - |
Plasmodium falciparum |
Leucyl aminopeptidase | - |
Plasmodium falciparum |
metallo-aminopeptidase M1 | - |
Plasmodium falciparum |
Pf-LAP | - |
Plasmodium falciparum |
PfA-M1 | - |
Plasmodium falciparum |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000029 | - |
(2S,17S,20S,21R)-21-amino-5-(4-benzoylbenzyl)-2-[4-(hex-5-ynoylamino)butyl]-20-hydroxy-17-(naphthalen-2-ylmethyl)-4,7,16,19-tetraoxo-22-phenyl-9,12-dioxa-3,6,15,18-tetraazadocosan-1-amide | pH 7.5, temperature not specified in the publication | Plasmodium falciparum | |
0.00026 | - |
N-[(2-[2-[(N-[(2S,3R)-3-amino-4-[4-(benzyloxy)phenyl]-2-hydroxybutanoyl]-L-alanyl)amino]ethoxy]ethoxy)acetyl]-4-benzoylphenylalanyl-N6-hex-5-ynoyl-L-lysinamide | pH 7.5, temperature not specified in the publication | Plasmodium falciparum | |
0.00033 | - |
(2S,17S,20S,21R)-21-amino-5-(4-benzoylbenzyl)-2-[4-(hex-5-ynoylamino)butyl]-20-hydroxy-17-(naphthalen-2-ylmethyl)-4,7,16,19-tetraoxo-22-phenyl-9,12-dioxa-3,6,15,18-tetraazadocosan-1-amide | pH 7.5, temperature not specified in the publication | Plasmodium falciparum | |
0.004 | - |
N-[(2-[2-[(N-[(2S,3R)-3-amino-4-[4-(benzyloxy)phenyl]-2-hydroxybutanoyl]-L-alanyl)amino]ethoxy]ethoxy)acetyl]-4-benzoylphenylalanyl-N6-hex-5-ynoyl-L-lysinamide | pH 7.5, temperature not specified in the publication | Plasmodium falciparum |
General Information | Comment | Organism |
---|---|---|
malfunction | inhibition caused swelling of the parasite digestive vacuole and prevented proteolysis of hemoglobin derived oligopeptides, likely starving the parasite resulting in death | Plasmodium falciparum |
malfunction | inhibition is lethal to parasites early in the life cycle, prior to the onset of hemoglobin degradation | Plasmodium falciparum |